Related references
Note: Only part of the references are listed.The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
Reineke A. Schoot et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Toxicity of upfront 131I-metaiodobenzylguanidine (131I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
Gitta Bleeker et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma
Sarah French et al.
PEDIATRIC BLOOD & CANCER (2013)
Acute changes in blood pressure in patients with neuroblastoma treated with 131I-metaiodobenzylguanidine (MIBG)
Thalia Wong et al.
PEDIATRIC BLOOD & CANCER (2013)
Long-Term Follow-Up of the Thyroid Gland After Treatment With 131I-Metaiodobenzylguanidine in Children With Neuroblastoma: Importance of Continuous Surveillance
S. C. Clement et al.
PEDIATRIC BLOOD & CANCER (2013)
Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
Steven G. DuBois et al.
CLINICAL CANCER RESEARCH (2012)
Hypertension complicating 131I-meta-iodobenzylguanidine therapy for neuroblastoma
Michael A. Kosmin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial
Katherine K. Matthay et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma
Yuya Sato et al.
ITALIAN JOURNAL OF PEDIATRICS (2012)
Successful tandem (autologous-cord blood) SCT in advanced neuroblastomas with highly amplified MYCN
K. Goi et al.
BONE MARROW TRANSPLANTATION (2011)
Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems
Swati S. More et al.
CLINICAL CANCER RESEARCH (2011)
Safety and Efficacy of Tandem 131I-Metaiodobenzylguanidine Infusions in Relapsed/Refractory Neuroblastoma
Kelsey Johnson et al.
PEDIATRIC BLOOD & CANCER (2011)
Treatment of Advanced Neuroblastoma in Children Over 1 Year of Age: The Critical Role of 131I-Metaiodobenzylguanidine Combined With Chemotherapy in a Rapid Induction Regimen
Stefano Mastrangelo et al.
PEDIATRIC BLOOD & CANCER (2011)
Comparison of High-Specific-Activity Ultratrace 123/131I-MIBG and Carrier-Added 123/131I-MIBG on Efficacy, Pharmacokinetics, and Tissue Distribution
John A. Barrett et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging
Emilio Bombardieri et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
Malcolm A. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
This Week in the Journal
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Radiation Dosimetry, Pharmacokinetics, and Safety of Ultratrace™ Iobenguane I-131 in Patients with Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid
R. Edward Coleman et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2009)
Iodine-131-Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study
Katherine K. Matthay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age
Jan de Kraker et al.
EUROPEAN JOURNAL OF CANCER (2008)
EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
Francesco Giammarile et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Iodine-131-metaiodobenzyguanidine therapy with reduced-intensity allogeneic stem cell transplantation in recurrent neuroblastoma
Hiroka Takahashi et al.
PEDIATRIC BLOOD & CANCER (2008)
Transient sialoadenitis:: A complication of 131I-Metaiodobenzylguanidine therapy
Shakeel Modak et al.
PEDIATRIC BLOOD & CANCER (2008)
Clinical experience with alpha-particle-emitting At-211: Treatment of recurrent brain tumor patients with At-211-labeled chimeric antitenascin monoclonal antibody 81C6
Michael R. Zalutsky et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Graft-versus-tumour effect in refractory metastatic neuroblastoma
A. Marabelle et al.
BONE MARROW TRANSPLANTATION (2007)
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma
Katherine K. Matthay et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: A new approaches to neuroblastoma therapy consortium study
KK Matthay et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group
WB London et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
F Berthold et al.
LANCET ONCOLOGY (2005)
Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma
MN Gaze et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2005)
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma
SG DuBois et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Targeted radiotherapy with submyeloablative doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma
TI Kang et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Secondary myelodysplastic syndrome and leukemia following 131I-metaiodobenzylguanidine therapy for relapsed neuroblastoma
B Weiss et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2003)
Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation
M Inoue et al.
BONE MARROW TRANSPLANTATION (2003)
Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine
A Garaventa et al.
CANCER (2003)
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma
GA Yanik et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy
S Mastrangelo et al.
BRITISH JOURNAL OF CANCER (2001)
Astatine-211-labeled radiotherapeutics: An emerging approach to targeted alpha-particle radiotherapy
MR Zalutsky et al.
CURRENT PHARMACEUTICAL DESIGN (2000)
Share Paper
